Physicians’ Perceptions of Barriers to Cardiovascular Disease Risk Factor Control among Patients with Diabetes: Results from the Translating Research into Action for Diabetes (TRIAD) Study

References

1. ↵
   Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA 2003; 290: 1884–90.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   Killilea T. Long-term consequences of type 2 diabetes mellitus: economic impact on society and managed care. Am J Manag Care 2002; (16 Suppl): S441–9.
3. Susman JL, Helseth LD. Reducing the complications of type II diabetes: a patient-centered approach. Am Fam Physician 1997; 56: 471–80.

   OpenUrlPubMedWeb of Science
4. Huse DM, Oster G, Killen AR, Lacey MJ, Colditz GA. The economic costs of non-insulin-dependent diabetes mellitus. JAMA 1989; 262: 2708–13.

   OpenUrlCrossRefPubMedWeb of Science
5. Hogan P, Dall T, Nikolov P, American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 2003; 26: 917–32.

   OpenUrlAbstract/FREE Full Text
6. ↵
   Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837–53.

   OpenUrlCrossRefPubMedWeb of Science
7. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. New Engl J Med 2000; 342: 145–53.

   OpenUrlCrossRefPubMedWeb of Science
8. Collins R, Armitage J, Parish S, Sleigh P, Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003; 361: 2005–16.

   OpenUrlCrossRefPubMedWeb of Science
9. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006; 166: 1836–41.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    Committee on the Future of Primary Care, Institute of Medicine, Donaldson MS, Yordy KD, Lohr KN, Vanselow NA, eds. Primary care: America's health in a new era. Washington, D.C.: National Academies Press; 1996.
11. ↵
    Mold JW, Fryer GE, Phillips RL Jr, Dovey SM, Green LA. Family physicians are the main source of primary health care for the Medicare population. Am Fam Physician 2002; 66: 2032.

    OpenUrlPubMed
12. ↵
    Schmittdiel J, Uratsu C, Karter A, et al. Why don’t diabetes patients achieve recommended risk factor targets? Poor Adherence versus lack of treatment intensification. J Gen Intern Med 2008; 23: 588–94.

    OpenUrlCrossRefPubMedWeb of Science
13. Tseng C, Tierney EF, Gerzoff RB, et al. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study. Diabetes Care 2008; 31: 261–6.

    OpenUrlAbstract/FREE Full Text
14. ↵
    Ziemer DC, Miller CD, Rhee MK, et al. Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ 2005; 31: 564–71.

    OpenUrlAbstract/FREE Full Text
15. ↵
    Grant R, Adams AS, Trinacty CM, et al. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care 2007; 30: 807–12.

    OpenUrlAbstract/FREE Full Text
16. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA 2002; 288: 1909–4.

    OpenUrlCrossRefPubMedWeb of Science
17. Glasgow RE, Funnell MM, Bonomi AE, Davis C, Beckham V, Wagner EH. Self-management aspects of the improving chronic illness care breakthrough series: implementation with diabetes and heart failure teams. Ann Behav Med 2002; 24: 80–7.

    OpenUrlCrossRefPubMedWeb of Science
18. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA 2002; 288: 2469–75.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006; 19: 1190–6.

    OpenUrlAbstract/FREE Full Text
20. ↵
    Saberi S, Heisler M. Speaking the same language? Contrasting provider and patient definitions of good diabetes control. Prim Care Diabetes 2008; 10: 270–80.

    OpenUrl
21. ↵
    Loewe R, Freeman J. Interpreting diabetes mellitus: differences between patient and provider models of disease and their implications for clinical practice. Cult Med Psychiatry 2000; 24: 379–401.

    OpenUrlCrossRefPubMedWeb of Science
22. ↵
    Heisler M, Vijan S, Anderson RM, Ubel PA, Bernstein SJ, Hofer TP. When do patients and their physicians agree on diabetes treatment goals and strategies, and what difference does it make? J Gen Intern Med 2003; 18: 893–902.

    OpenUrlCrossRefPubMedWeb of Science
23. ↵
    Dicicco-Bloom B, Crabtree BF. The qualitative research interview. Med Educ 2006; 40: 314–21.

    OpenUrlCrossRefPubMedWeb of Science
24. ↵
    TRIAD Study Group. The Translating Research Into Action for Diabetes (TRIAD) study: a multicenter study of diabetes in managed care. Diabetes Care 2002; 25: 386–9.

    OpenUrlFREE Full Text
25. ↵
    ATLAS.ti: the knowledge workbench [computer program]. Version WIN 5.2.9. Berlin: ATLAS.ti Scientific Software Development GmbH; 2003–2005.
26. ↵
    Crabtree BF, Miller WL. Using codes and code manuals: a template organizing style of interpretation. In: Crabtree BF, Miller WL, eds. Doing qualitative research. 2nd ed. Thousand Oaks, CA: Sage Publications; 1999: 163–77.
27. ↵
    Addison R. A grounded hermeneutic editing organizing style of interpretation. In: Crabtree BF, Miller WL, eds. Doing qualitative research. 2nd ed. Thousand Oaks, CA: Sage Publications; 1999: 145–61.
28. ↵
    Wens J, Vermeire E, Royen PV, et al. GPs’ perspectives of type 2 diabetes patients’ adherence to treatment: a qualitative analysis of barriers and solutions. BMC Fam Pract 2005; 6: 20.

    OpenUrlCrossRefPubMed
29. ↵
    May C, Allison G, Chapple A, et al. Framing the doctor-patient relationship in chronic illness: a comparative study of general practitioners’ accounts. Sociol Health Iln 2004; 26: 135–58.

    OpenUrl
30. ↵
    Anderson RM, Funnell MM. Compliance and adherence are dysfunctional concepts in diabetes care. Diabetes Educ 2000; 26: 597–604.

    OpenUrlFREE Full Text
31. ↵
    Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998; 36: 1138–61.

    OpenUrlCrossRefPubMedWeb of Science
32. ↵
    Flocke SA, Miller WL, Crabtree BF. Relationships between physician practice style, patient satisfaction, and attributes of primary care. [See comment.] J Fam Pract 2002; 51: 835–40.

    OpenUrl
33. Miller WR, Rollnick S. Motivational interviewing: preparing people for change. 2nd ed. New York: Guilford Press; 2002.
34. Heisler M, Resnicow K. Helping patients make and sustain healthy changes: a brief introduction to the use of motivational interviewing approaches in clinical diabetes care. Clin Diabetes 2008; 26: 161–5.

    OpenUrlFREE Full Text
35. Resnicow K, DiIorio C, Soet JE, Ernst D, Borrelli B, Hecht J. Motivational interviewing in health promotion: it sounds like something is changing. Health Psychol 2002; 21: 444–51.

    OpenUrlCrossRefPubMedWeb of Science
36. Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract 2005; 55: 305–12.

    OpenUrlAbstract/FREE Full Text
37. Britt E, Hudson SM, Blampied NM. Motivational interviewing in health settings: a review. Patient Educ Couns 2004; 53: 147–55.

    OpenUrlCrossRefPubMedWeb of Science